Top compounds associated with response to SLC6A13


Feature Type Standardized
Nominal ANOVA
mRNA triptolide CTRPv2 pan-cancer AAC -0.063 0.07
mRNA AC220 GDSC1000 pan-cancer AAC 0.065 0.07
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.063 0.07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.07
mRNA PD-0332991 CCLE pan-cancer AAC 0.088 0.07
mRNA FH535 GDSC1000 pan-cancer AAC 0.064 0.07
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.071 0.07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.08
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA PF-573228 CTRPv2 pan-cancer AAC 0.059 0.08
Download CSV